Company intelligence / Profile preview

Pattern

Austin, Texas, United States

Ownership: Private
Employees: ~85
Development stage: Other

Overview

Pattern Bioscience is a biotechnology company specializing in rapid diagnostic solutions for infectious diseases. The company's proprietary Digital Phenotyping platform utilizes single-cell microbiology and machine learning to identify pathogens and determine their antibiotic susceptibility in hours rather than days. This technology is designed to combat antimicrobial resistance and improve patient outcomes in critical care settings, such as sepsis management. By providing fast, phenotypic results directly from clinical samples, Pattern Bioscience enables clinicians to initiate targeted therapy much earlier.

Therapeutic areas: Infectious Diseases
Modalities: Device
Industry: Pathology

Beyond the preview

Go deeper on Pattern.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pattern.

Explore the full profile